Dear Colleagues and Friends, Ladies and Gentlemen，

On behalf of the Organizing Committee, we warmly welcome you to join the 2025 International Forum on Nanobiopharmaceutical Technology and Industry Development (ChinaIFNTID 2025), which will be held in Xi'an China from April 11-13, 2025. The conference theme of ChinaIFNTID 2025 is “Focuses on advancing the integration of nanotechnology with biopharmaceutical sciences to enhance therapeutic innovation and industrial growth. This theme aims to explore how nanotechnology can drive breakthroughs in drug delivery systems, targeted therapies, and regenerative medicine". 

The purpose of this conference is to advance the synergistic integration of nanotechnology and biomedicine, fields that together hold transformative potential for improving healthcare outcomes and creating innovative therapeutic approaches. A key objective of this event is to drive progress in nanobiomedicine, a discipline at the frontier of scientific exploration. By uniting global leaders in academia, clinical practice, and industry, we aim to foster a multidisciplinary dialogue that encourages both basic and translational research. The conference is designed not only to showcase cutting-edge scientific achievements but also to address the challenges associated with bringing nanobiotechnology to the market and clinical practice. This involves facilitating discussions on topics such as scalable manufacturing of nanomaterials, regulatory considerations, and clinical trial design, which are essential to ensuring that innovations can move smoothly from the lab bench to the bedside. Additionally, the conference will provide a platform to explore ethical and societal considerations, fostering a responsible approach to the adoption of nanobiomedicine.

Furthermore, the gathering aims to support young scientists and emerging researchers by providing opportunities for networking, mentorship, and collaboration. By bridging basic science and applied research, we hope to catalyze new insights and solutions in areas like targeted drug delivery, minimally invasive surgery, and cancer therapy, ultimately advancing the efficacy and accessibility of medical treatments worldwide.

Your presence at this conference is our greatest support, and we extend our heartfelt thanks to all our distinguished guests, participants, and members of both the academic and organizing committees. Your invaluable contributions, thoughtful suggestions, and dedicated efforts have enabled us to craft a vibrant and impactful program. This event is a testament to your hard work, and without your commitment, such a high-caliber conference would not be possible. Your participation ensures that the conference upholds the highest standards of excellence. We are committed to making this a truly memorable and engaging experience for all, and we look forward to an inspiring and successful gathering together.

Best regards，